RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 372 - per page Next page
Order by
Vascular Clip and Devices for Sutureless Anastomosis and Bypasses (08-31_09-09)
Novel Surgical Clips for Vascular Bypass and Tissue Grafts for Vascular surgery, vascular grafts, sutureless anastomosis and bypass surgery More
Encased Stent, E-STENT (02-27)
An Endothelial lined Stent for Rapid Endothelialization and Preventing Restenosis More
Detection of clinically relevant protein variants
Easy detection of haemoglobinopathies through use of MSMS. More
BiliSuit – a Fiber optic LED form fitting garment for treatment of infant hyperbilirubinemia (09-03)
Portable phototherapy device to treat jaundiced infants More
Evi27 Gene Sequence and Protein Encoded Thereby (cancer diagnostics) (98-18)
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
Use of Biological Surfactant as Anti-flammatory Agent and Tissue Preservative Solution
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
METHODS FOR SCREENING A THERAPEUTIC AGENT OF HEART FAILURE, FIBROSIS AND INFLAMMATION AND COMPOSITIONS COMPRISING THE SAME
Heart failure is associated with cardiac hypertropy, atheiosclerosis, myocardial infarction, valvular heart disease and hypertension. Many researches has focused on development of cardiotonics for treating heart failure. More
RayVaTM (IND to be filed (for SPA Phase III Registration Clinical Trials) Phase 2/3 - Alprostadil/DDAIP, Raynaud's Syndrome Secondary to Scleroderma)
NexMed is developing RayVaTM, a topical treatment for Raynaud’s syndrome and incorporates alprostadil with the NexACT® proprietary permeation enhancer (DDAIP.HCL). More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Methods and Apparatus for Minimal Invasive Extirpating of Aortic Arch Protruding Thrombus
Methods and Apparatus for Minimal Invasive Extirpating of Aortic Arch Protruding Thrombus More
Displaying 1..10 of 372 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.innovaro.com
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Nov 2010 - 330 pages - $1,495
Deals and alliances in blood and lymphatic diseases
Jun 2006 - 556 pages - $2,495
National Heart, Lung, and Blood Institute – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Apr 2010 - 510 pages - $2,695
Early Diagnosis of Alzheimer’s Disease - Benefits, Challenges and Recent Developments
Mar 2011 - 5 pages - $500
Terumo to Buy Blood Transfusion Business from Gambro: To become the Largest Player in the Blood Transfusion Market - Deal Analysis From GlobalData
Mar 2011 - 6 pages - $500
Pre-clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
Jun 2010 - 319 pages - $2,695
CardioVascular BioTherapeutics, Inc. (CVBT) - Strategic SWOT Analysis Review
May 2011 - 23 pages - $125
CardioVascular BioTherapeutics, Inc. (CVBT) - Financial and Strategic Analysis Review
Sep 2010 - 25 pages - $125
The Arab Pharmaceutical Manufacturing Co. Ltd. (APMC) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us